Key Details
Last Dividend
$0.14Annual EPS
-$2.99Annual ROE
-127.92%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 04, 2022Recent annual earnings:
Mar 09, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
Dec 26, 2023Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
06 Dec '22 HC Wainwright & Co.
Neutral01 Dec '22 Chardan Capital
Neutral15 June '22 Chardan Capital
Buy19 May '22 Piper Sandler
Overweight28 Mar '22 HC Wainwright & Co.
Buy16 Mar '21 Maxim Group
Buy27 Oct '20 Piper Sandler
Overweight27 Oct '20 Jefferies
BuyScreeners with ONCR included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Why Is Oncorus (ONCR) Stock Down 27% Today?
ONCR
InvestorPlace12 June 2023
Oncorus (NASDAQ: ONCR ) stock is taking a beating on Monday after revealing plans for an upcoming special shareholder meeting. According to a filing with the Securities and Exchange Commission (SEC), Oncorus is seeking investor attendance at the meeting to vote on certain matters.
Oncorus (ONCR) Dips 37% on Layoff Plan & Bankruptcy Threat
ONCR
Zacks Investment Research05 June 2023
Oncorus (ONCR) decides to lay off nearly all of its workforce since it is facing challenges in raising additional capital. This lay off is expected to be completed by August 2023.
FAQ
- What is the primary business of Oncorus?
- What is the ticker symbol for Oncorus?
- Does Oncorus pay dividends?
- What sector is Oncorus in?
- What industry is Oncorus in?
- What country is Oncorus based in?
- When did Oncorus go public?
- Is Oncorus in the S&P 500?
- Is Oncorus in the NASDAQ 100?
- Is Oncorus in the Dow Jones?
- When was Oncorus's last earnings report?
- When does Oncorus report earnings?
- Should I buy Oncorus stock now?
What is the primary business of Oncorus?
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.
What is the ticker symbol for Oncorus?
The ticker symbol for Oncorus is NASDAQ:ONCR
Does Oncorus pay dividends?
No, Oncorus does not pay dividends
What sector is Oncorus in?
Oncorus is in the Healthcare sector
What industry is Oncorus in?
Oncorus is in the Biotechnology industry
What country is Oncorus based in?
Oncorus is headquartered in United States
When did Oncorus go public?
Oncorus's initial public offering (IPO) was on 02 October 2020
Is Oncorus in the S&P 500?
No, Oncorus is not included in the S&P 500 index
Is Oncorus in the NASDAQ 100?
No, Oncorus is not included in the NASDAQ 100 index
Is Oncorus in the Dow Jones?
No, Oncorus is not included in the Dow Jones index
When was Oncorus's last earnings report?
Oncorus's most recent earnings report was on 4 August 2022
When does Oncorus report earnings?
The date for Oncorus's next earnings report has not been announced yet
Should I buy Oncorus stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions